Dackus, Gwen M. H. E.
Jóźwiak, Katarzyna
van der Wall, Elsken
van Diest, Paul J.
Hauptmann, Michael
Siesling, Sabine
Sonke, Gabe S.
Linn, Sabine C. http://orcid.org/0000-0001-5541-0347
Funding for this research was provided by:
Stichting A Sister's Hope
De Vrienden van UMC Utrecht
ZonMw (836021019)
University Medical Center Utrecht
Article History
Received: 11 May 2020
Accepted: 9 October 2020
First Online: 28 October 2020
Compliance with ethical standards
:
: GSS has received institutional research support funding from AstraZeneca, Merck, Novartis, and Roche outside the submitted work. SCL reports grants from ZonMw and A Sister's Hope during the conduct of the study. SCL is an advisory board member for AstraZeneca, Cergentis, IBM, Pfizer and Roche and received grants from AstraZeneca, Eurocept-pharmaceuticals, Genentech, Novartis, Pfizer, Roche, Tesaro and Immunomedics, in addition, SCL received non-financial support from Genentech, Novartis, Roche, Tesaro and Immunomedics and other from AstraZeneca, Pfizer, Cergentis, IBM and Bayer outside of this study. All remaining authors declare that they have no conflict of interest.
: This project was approved by the Medical Ethical Committee of the Netherlands Cancer Institute – Antoni van Leeuwenhoek hospital (PTC12.1262/NBCP). Data use was approved by the Committee of Privacy of the Netherlands Cancer Registry.